Arca Biopharma taps new CFO, clinical development chief

WESTMINSTER — Arca Biopharma Inc. (Nasdaq: ABIO) hired Jeff Dekker and Christopher Graybill as the company’s chief financial officer and vice president of clinical development, respectively.

Dekker was most recently vice president of finance at Louisville-based biotechnology company GlobeImmune Inc., where he held finance roles for more than 15 years. He replaces Brian Selby, who left after 14 years at Arca.

Graybill was most recently at Lakewood-based Terumo BCT, the blood and cell-technology arm of Tokyo-based medical-device maker Terumo Corp., where he held global clinical affairs and research for just more than six years. He also had stints at…